FMT
KRTX

First Mercantile Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

First Mercantile Trust’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$88K Buy
722
+50
+7% +$5.77K 0.01% 696
2021
Q2 		$77K Buy
672
+311
+86% +$36.4K 0.01% 747
2021
Q1 		$43K Buy
+361
New +$40.9K ﹤0.01% 792

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

First Mercantile Trust's KRTX Position: Q3 2021 in Review

First Mercantile Trust increased its Karuna Therapeutics, Inc. Common Stock (KRTX) stake by 7.4% in Q3 2021, buying an estimated $5.77K and bringing the position to 722 shares worth $88K. The position accounts for 0.01% of the portfolio, ranked #696.

First Mercantile Trust first reported a position in KRTX in Q1 2021 and has held it in 3 quarters since. 159 funds tracked by Wall St. Rank hold KRTX as of Q3 2021.

  • First Mercantile Trust held 722 shares of Karuna Therapeutics, Inc. Common Stock worth $88K as of Q3 2021.
  • First Mercantile Trust bought 50 Karuna Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $5.77K.
  • Karuna Therapeutics, Inc. Common Stock made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #696 holding.
  • First Mercantile Trust first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and has held it in 3 quarters since.
  • 159 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.